Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学HER2 Resistance Mechanisms, Breast Cancer

Neil Bhatt

MD

🏢Vanderbilt University Medical Center🌐USA

Associate Professor of Medical Oncology

32
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Neil Bhatt investigates mechanisms of resistance to HER2-targeted therapies in breast cancer, with emphasis on HER2 somatic mutations in previously HER2-negative tumors. His research characterized how HER2 kinase domain mutations confer sensitivity to irreversible HER2 inhibitors like neratinib. He has also studied PI3K pathway activation and HER3 upregulation as adaptive resistance mechanisms to trastuzumab. His translational work informs the use of pan-HER inhibitors in HER2-mutant metastatic breast cancer.

Share:

🧪Research Fields 研究领域

lapatinib resistance
HER2 mutation breast
neratinib extended adjuvant
PI3K HER2 crosstalk
HER3 upregulation

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Neil Bhatt 的研究动态

Follow Neil Bhatt's research updates

留下邮箱,当我们发布与 Neil Bhatt(Vanderbilt University Medical Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment